Onderzoeker
Maxim Grymonprez
- Trefwoorden:Pharmaco-epidemiologie, hartaritmie
- Disciplines:Cardiologie, Biostatistiek, Epidemiologie
Affiliaties
- Vakgroep Bioanalyse (Departement)
Lid
Vanaf1 okt 2019 → 4 okt 2023
Projecten
1 - 2 of 2
- Rationeel gebruik van antitrombotica bij een populatie met voorkamerfibrillatieVanaf1 nov 2019 → 4 okt 2023Financiering: FWO mandaten
- Rationeel gebruik van antitrombotica bij een populatie met voorkamerfibrillatieVanaf1 okt 2019 → 1 nov 2019Financiering: BOF - doctorale mandaten
Publicaties
1 - 10 van 22
- Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation : a nationwide cohort study(2024)
Auteurs: Maxim Grymonprez, Mirko Petrovic, Tine De Backer, Stephane Steurbaut, Lies Lahousse
Pagina's: 55 - 65 - Potentially inappropriate prescribing in multimorbid and polymedicated older adults with AF : a systematic review and meta-analysis(2024)
Auteurs: Cheïma Amrouch, Delphine Vauterin, Souad Amrouch, Maxim Grymonprez, Lu Dai, Cecilia Damiano, Amaia Calderón-Larrañaga, Lies Lahousse, Dirk De Bacquer, Gregory Y. H. Lip, et al.
Pagina's: 13 - 30 - Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019 : a nationwide cohort study(2023)
Auteurs: Maxim Grymonprez, Andreas Capiau, Delphine Vauterin, Els Mehuys, Koen Boussery, Stephane Steurbaut, Lies Lahousse
Pagina's: 1360 - 1373 - Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists : a Belgian nationwide cohort study(2023)
Auteurs: Maxim Grymonprez, M Arfan Ikram, Stephane Steurbaut, Lies Lahousse
- Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis(2023)
Auteurs: Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine De Backer, Lies Lahousse
Pagina's: 781 - 791 - Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation : a qualitative approach(2023)
Auteurs: Andreas Capiau, Maxim Grymonprez, Sophie Scheire, Lies Lahousse, Els Mehuys, Tine De Backer, Koen Boussery
Pagina's: 164 - 169 - Clinical outcomes in patients with atrial fibrillation and a history of falls using non-vitamin K antagonist oral anticoagulants : a nationwide cohort study(2023)
Auteurs: Maxim Grymonprez, Mirko Petrovic, Tine De Backer, Stephane Steurbaut, Lies Lahousse
- Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation : a nationwide cohort study(2023)
Auteurs: Maxim Grymonprez, Xander Bertels, Stephane Steurbaut, Lies Lahousse
- Worldwide trends in oral anticoagulant use in patients with atrial fibrillation from 2010 to 2018 : a systematic review and meta-analysis(2022)
Auteurs: Maxim Grymonprez, Cynthia Simoens, Stephane Steurbaut, Tine De Backer, Lies Lahousse
Pagina's: 887 - 898 - Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation and (morbid) obesity or low body weight : a systematic review and meta-analysis(2022)
Auteurs: Maxim Grymonprez, Tine De Backer, Stephane Steurbaut, Koen Boussery, Lies Lahousse
Pagina's: 749 - 761